Malignant Tumor of Lung
1 clinical trials · Condition
◉ Watch Malignant Tumor of Lung
| Record | Firm | Date |
|---|---|---|
| Almonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance Status (NCT05826483) | Guangzhou Institute of Respiratory Disease | 2022-01-01 |
Track Malignant Tumor of Lung automatically
Every clearance here is in the API, with alerts when new ones post.